Cargando…
Lysophosphatidylcholine Triggers TLR2- and TLR4-Mediated Signaling Pathways but Counteracts LPS-Induced NO Synthesis in Peritoneal Macrophages by Inhibiting NF-κB Translocation and MAPK/ERK Phosphorylation
BACKGROUND: Lysophosphatidylcholine (LPC) is the main phospholipid component of oxidized low-density lipoprotein (oxLDL) and is usually noted as a marker of several human diseases, such as atherosclerosis, cancer and diabetes. Some studies suggest that oxLDL modulates Toll-like receptor (TLR) signal...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848743/ https://www.ncbi.nlm.nih.gov/pubmed/24312681 http://dx.doi.org/10.1371/journal.pone.0076233 |
_version_ | 1782293811700957184 |
---|---|
author | Carneiro, Alan Brito Iaciura, Bruna Maria Ferreira Nohara, Lilian Lie Lopes, Carla Duque Veas, Esteban Mauricio Cordero Mariano, Vania Sammartino Bozza, Patricia Torres Lopes, Ulisses Gazos Atella, Georgia Correa Almeida, Igor Correia Silva-Neto, Mário Alberto Cardoso |
author_facet | Carneiro, Alan Brito Iaciura, Bruna Maria Ferreira Nohara, Lilian Lie Lopes, Carla Duque Veas, Esteban Mauricio Cordero Mariano, Vania Sammartino Bozza, Patricia Torres Lopes, Ulisses Gazos Atella, Georgia Correa Almeida, Igor Correia Silva-Neto, Mário Alberto Cardoso |
author_sort | Carneiro, Alan Brito |
collection | PubMed |
description | BACKGROUND: Lysophosphatidylcholine (LPC) is the main phospholipid component of oxidized low-density lipoprotein (oxLDL) and is usually noted as a marker of several human diseases, such as atherosclerosis, cancer and diabetes. Some studies suggest that oxLDL modulates Toll-like receptor (TLR) signaling. However, effector molecules that are present in oxLDL particles and can trigger TLR signaling are not yet clear. LPC was previously described as an attenuator of sepsis and as an immune suppressor. In the present study, we have evaluated the role of LPC as a dual modulator of the TLR-mediated signaling pathway. METHODOLOGY/PRINCIPAL FINDINGS: HEK 293A cells were transfected with TLR expression constructs and stimulated with LPC molecules with different fatty acid chain lengths and saturation levels. All LPC molecules activated both TLR4 and TLR2-1 signaling, as evaluated by NF-қB activation and IL-8 production. These data were confirmed by Western blot analysis of NF-қB translocation in isolated nuclei of peritoneal murine macrophages. However, LPC counteracted the TLR4 signaling induced by LPS. In this case, NF-қB translocation, nitric oxide (NO) synthesis and the expression of inducible nitric oxide synthase (iNOS) were blocked. Moreover, LPC activated the MAP Kinases p38 and JNK, but not ERK, in murine macrophages. Interestingly, LPC blocked LPS-induced ERK activation in peritoneal macrophages but not in TLR-transfected cells. CONCLUSIONS/SIGNIFICANCE: The above results indicate that LPC is a dual-activity ligand molecule. It is able to trigger a classical proinflammatory phenotype by activating TLR4- and TLR2-1-mediated signaling. However, in the presence of classical TLR ligands, LPC counteracts some of the TLR-mediated intracellular responses, ultimately inducing an anti-inflammatory phenotype; LPC may thus play a role in the regulation of cell immune responses and disease progression. |
format | Online Article Text |
id | pubmed-3848743 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-38487432013-12-05 Lysophosphatidylcholine Triggers TLR2- and TLR4-Mediated Signaling Pathways but Counteracts LPS-Induced NO Synthesis in Peritoneal Macrophages by Inhibiting NF-κB Translocation and MAPK/ERK Phosphorylation Carneiro, Alan Brito Iaciura, Bruna Maria Ferreira Nohara, Lilian Lie Lopes, Carla Duque Veas, Esteban Mauricio Cordero Mariano, Vania Sammartino Bozza, Patricia Torres Lopes, Ulisses Gazos Atella, Georgia Correa Almeida, Igor Correia Silva-Neto, Mário Alberto Cardoso PLoS One Research Article BACKGROUND: Lysophosphatidylcholine (LPC) is the main phospholipid component of oxidized low-density lipoprotein (oxLDL) and is usually noted as a marker of several human diseases, such as atherosclerosis, cancer and diabetes. Some studies suggest that oxLDL modulates Toll-like receptor (TLR) signaling. However, effector molecules that are present in oxLDL particles and can trigger TLR signaling are not yet clear. LPC was previously described as an attenuator of sepsis and as an immune suppressor. In the present study, we have evaluated the role of LPC as a dual modulator of the TLR-mediated signaling pathway. METHODOLOGY/PRINCIPAL FINDINGS: HEK 293A cells were transfected with TLR expression constructs and stimulated with LPC molecules with different fatty acid chain lengths and saturation levels. All LPC molecules activated both TLR4 and TLR2-1 signaling, as evaluated by NF-қB activation and IL-8 production. These data were confirmed by Western blot analysis of NF-қB translocation in isolated nuclei of peritoneal murine macrophages. However, LPC counteracted the TLR4 signaling induced by LPS. In this case, NF-қB translocation, nitric oxide (NO) synthesis and the expression of inducible nitric oxide synthase (iNOS) were blocked. Moreover, LPC activated the MAP Kinases p38 and JNK, but not ERK, in murine macrophages. Interestingly, LPC blocked LPS-induced ERK activation in peritoneal macrophages but not in TLR-transfected cells. CONCLUSIONS/SIGNIFICANCE: The above results indicate that LPC is a dual-activity ligand molecule. It is able to trigger a classical proinflammatory phenotype by activating TLR4- and TLR2-1-mediated signaling. However, in the presence of classical TLR ligands, LPC counteracts some of the TLR-mediated intracellular responses, ultimately inducing an anti-inflammatory phenotype; LPC may thus play a role in the regulation of cell immune responses and disease progression. Public Library of Science 2013-09-30 /pmc/articles/PMC3848743/ /pubmed/24312681 http://dx.doi.org/10.1371/journal.pone.0076233 Text en © 2013 Carneiro et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Carneiro, Alan Brito Iaciura, Bruna Maria Ferreira Nohara, Lilian Lie Lopes, Carla Duque Veas, Esteban Mauricio Cordero Mariano, Vania Sammartino Bozza, Patricia Torres Lopes, Ulisses Gazos Atella, Georgia Correa Almeida, Igor Correia Silva-Neto, Mário Alberto Cardoso Lysophosphatidylcholine Triggers TLR2- and TLR4-Mediated Signaling Pathways but Counteracts LPS-Induced NO Synthesis in Peritoneal Macrophages by Inhibiting NF-κB Translocation and MAPK/ERK Phosphorylation |
title | Lysophosphatidylcholine Triggers TLR2- and TLR4-Mediated Signaling Pathways but Counteracts LPS-Induced NO Synthesis in Peritoneal Macrophages by Inhibiting NF-κB Translocation and MAPK/ERK Phosphorylation |
title_full | Lysophosphatidylcholine Triggers TLR2- and TLR4-Mediated Signaling Pathways but Counteracts LPS-Induced NO Synthesis in Peritoneal Macrophages by Inhibiting NF-κB Translocation and MAPK/ERK Phosphorylation |
title_fullStr | Lysophosphatidylcholine Triggers TLR2- and TLR4-Mediated Signaling Pathways but Counteracts LPS-Induced NO Synthesis in Peritoneal Macrophages by Inhibiting NF-κB Translocation and MAPK/ERK Phosphorylation |
title_full_unstemmed | Lysophosphatidylcholine Triggers TLR2- and TLR4-Mediated Signaling Pathways but Counteracts LPS-Induced NO Synthesis in Peritoneal Macrophages by Inhibiting NF-κB Translocation and MAPK/ERK Phosphorylation |
title_short | Lysophosphatidylcholine Triggers TLR2- and TLR4-Mediated Signaling Pathways but Counteracts LPS-Induced NO Synthesis in Peritoneal Macrophages by Inhibiting NF-κB Translocation and MAPK/ERK Phosphorylation |
title_sort | lysophosphatidylcholine triggers tlr2- and tlr4-mediated signaling pathways but counteracts lps-induced no synthesis in peritoneal macrophages by inhibiting nf-κb translocation and mapk/erk phosphorylation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848743/ https://www.ncbi.nlm.nih.gov/pubmed/24312681 http://dx.doi.org/10.1371/journal.pone.0076233 |
work_keys_str_mv | AT carneiroalanbrito lysophosphatidylcholinetriggerstlr2andtlr4mediatedsignalingpathwaysbutcounteractslpsinducednosynthesisinperitonealmacrophagesbyinhibitingnfkbtranslocationandmapkerkphosphorylation AT iaciurabrunamariaferreira lysophosphatidylcholinetriggerstlr2andtlr4mediatedsignalingpathwaysbutcounteractslpsinducednosynthesisinperitonealmacrophagesbyinhibitingnfkbtranslocationandmapkerkphosphorylation AT noharalilianlie lysophosphatidylcholinetriggerstlr2andtlr4mediatedsignalingpathwaysbutcounteractslpsinducednosynthesisinperitonealmacrophagesbyinhibitingnfkbtranslocationandmapkerkphosphorylation AT lopescarladuque lysophosphatidylcholinetriggerstlr2andtlr4mediatedsignalingpathwaysbutcounteractslpsinducednosynthesisinperitonealmacrophagesbyinhibitingnfkbtranslocationandmapkerkphosphorylation AT veasestebanmauriciocordero lysophosphatidylcholinetriggerstlr2andtlr4mediatedsignalingpathwaysbutcounteractslpsinducednosynthesisinperitonealmacrophagesbyinhibitingnfkbtranslocationandmapkerkphosphorylation AT marianovaniasammartino lysophosphatidylcholinetriggerstlr2andtlr4mediatedsignalingpathwaysbutcounteractslpsinducednosynthesisinperitonealmacrophagesbyinhibitingnfkbtranslocationandmapkerkphosphorylation AT bozzapatriciatorres lysophosphatidylcholinetriggerstlr2andtlr4mediatedsignalingpathwaysbutcounteractslpsinducednosynthesisinperitonealmacrophagesbyinhibitingnfkbtranslocationandmapkerkphosphorylation AT lopesulissesgazos lysophosphatidylcholinetriggerstlr2andtlr4mediatedsignalingpathwaysbutcounteractslpsinducednosynthesisinperitonealmacrophagesbyinhibitingnfkbtranslocationandmapkerkphosphorylation AT atellageorgiacorrea lysophosphatidylcholinetriggerstlr2andtlr4mediatedsignalingpathwaysbutcounteractslpsinducednosynthesisinperitonealmacrophagesbyinhibitingnfkbtranslocationandmapkerkphosphorylation AT almeidaigorcorreia lysophosphatidylcholinetriggerstlr2andtlr4mediatedsignalingpathwaysbutcounteractslpsinducednosynthesisinperitonealmacrophagesbyinhibitingnfkbtranslocationandmapkerkphosphorylation AT silvanetomarioalbertocardoso lysophosphatidylcholinetriggerstlr2andtlr4mediatedsignalingpathwaysbutcounteractslpsinducednosynthesisinperitonealmacrophagesbyinhibitingnfkbtranslocationandmapkerkphosphorylation |